Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy joining 5 (IGHJ5)
- Target
- IGHJ5
- Molecular classification
- Other (Immunoglobulin gene segment)
01
Overview
Immunoglobulin heavy joining 5 (IGHJ5) is a gene segment within the immunoglobulin heavy chain (IGH) locus, encoding one of several possible joining (J) segments used during somatic recombination (VDJ recombination) in early B-cell development[1][2][6][10][11][12]. This process is essential for generating the diverse repertoire of antibodies required for the adaptive immune system in humans. The IGHJ5 segment, when joined with specific variable (V) and diversity (D) segments, forms part of the variable region of the immunoglobulin heavy chain, ultimately contributing to antigen binding diversity. IGHJ5 is not itself a receptor, enzyme, or independent therapeutic target, but rather a genomic element essential for antibody gene rearrangement[2][11]. Variation in IGHJ5 and related IGH segments may subtly influence immune function and susceptibility to disease, but the segment itself is not directly targeted by therapeutic drugs[8][12].
- Other names
- JH5bIGHJ5
02
Biological functions
Adaptive immune responseAntibody diversity generation
03
Disease associations
Other (Not considered a direct disease target; involved in immune repertoire and genetic variation can affect immunity)
Beyond the preview
Go deeper on Immunoglobulin heavy joining 5 (IGHJ5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin heavy joining 5 (IGHJ5).